Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. J Clin Oncol. 2016 Mar 10; 34(8):786-93.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Dacarbazine
Dioxoles
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Leiomyosarcoma
Liposarcoma
Male
Middle Aged
Survival Rate
Tetrahydroisoquinolines
Young Adult

authors with profiles

Robin Jones